| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. | Br J Cancer | 2010 | 2.51 |
| 2 | The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. | Br J Cancer | 2011 | 2.25 |
| 3 | LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling. | Br J Cancer | 2010 | 0.99 |